Jade S. Hiramoto

MD

Vascular surgeon

Dr. Jade Hiramoto is a vascular surgeon specializing in thoracic and abdominal aortic dissections and aneurysms, peripheral vascular disease, and extracranial cerebrovascular occlusive disease. Her skills encompass all aspects of endovascular (less invasive) procedures in addition to complex, traditional vascular surgeries.

Hiramoto's research focuses on outcomes for patients undergoing vascular surgery, specifically looking at risk factors and predictors for vascular disease.

Hiramoto's extensive training at UCSF includes her medical degree, residency in surgery, fellowships in interventional radiology and vascular surgery, and certification through the Advanced Training in Clinical Research program.

  • Education

    UCSF School of Medicine, 1996

  • Residencies

    UCSF Medical Center, Surgery, 2005

  • Fellowships

    UCSF Medical Center, Vascular Surgery, 2005

  • Board Certifications

    Surgery, American Board of Surgery

  • Academic Title

    Professor

Conditions I specialize in

Treatments I provide

Where I see patients (3)

    My reviews

    4.9

    Overall Experience
    156 Ratings
    About our process
    Dec 24, 2024
    Staff and Dr. Hiramoto were wonderful
    Nov 27, 2024
    An amazing doctor
    Oct 18, 2024
    Excellent
    Sep 17, 2024
    She's great!
    Aug 29, 2024
    My experiences were very good and I felt comfortable.
    Aug 27, 2024
    Done well
    Aug 20, 2024
    Dr. Hiramoto is an absolutely amazing doc. Confidence inspiring, empathetic, and totally professional
    Aug 06, 2024
    Very calming and assuring
    Aug 01, 2024
    Dr. Miramoto and her staff are just great. I could not ask for better care. Personal, professional, caring!
    Jun 26, 2024
    Although UCSF Medical Center is far where I live, I don't mind traveling just to see Dr. Hiramoto.
    May 23, 2024
    Very good experience. Everyone was professional, patient, friendly, caring and understanding.
    Apr 16, 2024
    Dr. Hiramoto and her team are the best.
    Apr 16, 2024
    I see Dr. Hiramoto once a year to check on my stent which became mine 11 years ago! She is an excellent doctor and a terrific human being!
    Mar 15, 2024
    I love my care providers at UCSF!
    Mar 08, 2024
    Excellent experience with both doctors and the ultrasound tech.
    Mar 08, 2024
    Awesome Doctor!
    Mar 05, 2024
    Everyone that I came in contact with was awesome. So reassured that I'm in good hands with my health issue. Thanks to the entire team.
    Nov 07, 2023
    Clear description of my condition, of course of action to take and of consequences of not following treatment plan
    Oct 18, 2023
    Oh, he's very concerned about questions that I have. Jade always addresses and answers my questions.
    Sep 26, 2023
    Excellent good
    Aug 22, 2023
    I love my care providers at UCSF
    Aug 15, 2023
    Totally impressive. Smart, but caring and engaged and efficient without making me feel rushed in any way.
    Aug 08, 2023
    Dr. Hiramoto has always been friendly and gracious toward me. She's also been very informative re: my health issues.
    Aug 01, 2023
    This physican and her staff should be models for all you offices
    Jul 21, 2023
    Dr. Hiramoto is always wonderful!!
    Jul 12, 2023
    Dr Hiramoto and her care staff were superb, made us feel like we were listened to and part of care decisions going forward. I feel very confident in their abilities.
    Mar 22, 2023
    Dr Hiramoto is outstanding. She comforted me while explaining the circumstances and procedure. She went into detail and asked me my thoughts and any follow up questions. I feel like I'm taken care of in a professional and caring manner.
    Mar 14, 2023
    Dr. Hiramoto is simply great.

    Selected research

    See all research
    Decorative Caduceus

    Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

    Proportion of patients with sac regression at 1 year, defined in accordance with SVS guidelines as the reduction in maximum diameter by >= 5 mm when compared to the first CT imaging study obtained within 90 days after index proced...

    Recruiting

    Contact me

    Share